Skip to main content

Table 3 Study population

From: Clinical evaluation of left ventricular function and morphology using an accelerated k-t sensitivity encoding method in cardiovascular magnetic resonance

 

Patients (n = 26)

Volunteers (n = 16)

p value

Demographics

 Age, years

53 ± 13

43 ± 14

< 0.001

 Male, n (%)

17 (65)

10 (63)

0.91

 BMI, kg/m2

29 ± 6

26 ± 3

0.004

 BSA, m2

1.91 ± 0.27

1.83 ± 0.24

0.33

 HR, bpm

68 ± 17

63 ± 17

0.73

 PVC, n (%)

1 (4%)

Cardiovascular risk factors

 Hypertension, n (%)

17 (65)

1 (6)

 Diabetes, n (%)

8 (31)

 Hypercholesterolemia, n (%)

11 (42)

 Smoking, n (%)

10 (39)

Diagnosis

 HCM, n (%)

7 (27)

 Ischemic heart disease, n (%)

6 (24)

 Chagas heart disease, n (%)

3 (11)

 DCM, n (%)

3 (11)

 Other cardiomyopathies, n (%)

7 (27)

CMR findingsa

 LVEDVI, mL/m2

92 ± 50

66 ± 10

0.01

 LVESVI, mL/m2

52 ± 53

26 ± 10

0.04

 LVMI, g/m2

80 ± 28

54 ± 10

< 0.001

 LVSV, mL

76 ± 25

75 ± 15

0.90

 LVEF, %

52 ± 21

62 ± 5

0.05

  1. BMI body index mass, BSA body surface area, HR heart rate, PVC premature ventricular contraction, HCM hypertrophic cardiomyopathy, DCM dilated cardiomyopathy, CMR cardiovascular magnetic resonance, LVEDVI left ventricle end-diastolic volume index, LVESVI left ventricle end-systolic volume index, LVMI left ventricle mass index, LVSV left ventricle stroke volume, LVEF left ventricle ejection fraction
  2. Plus-minus values are means ± SD
  3. aLV measurements obtained from 2D-SSFP cine